EUVIMEDEUVIMED entdecken
Crossref

Endoplasmic Reticulum-Targeting Iridium(III) Complexes Induce Pyroptosis and Enhance Immunogenic Cell Death in MDA-MB-231 Cells

Wei Wu, Jiaen Huang, Yuling Li, Jiaxi Chen, Xiaowei Kuang, Manzhen Ye, Rui Chen, Junli An, Zunnan Huang iD, Jing Sun iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Wei Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Dongguan Affiliated Hospital, School of Pharmacy, Guangdong Medical University, Dongguan 523808, P. R. China. Hauptthemen laut MEDLINE: Iridium, Pyroptosis, Immunogenic Cell Death, Endoplasmic Reticulum. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: the Medical Industry Innovation Project of Guangdong Medical University, the Key Scientific Research Projects of Colleges and Universities in Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has revolutionized oncology by leveraging host immunity to eliminate malignant cells. In this study, five iridium(III) complexes (Ir1-Ir5) were synthesized and evaluated for their in vitro antitumor activity against various tumor cell lines. Among these, Ir4 and Ir5 exhibited the highest cytotoxicity and the most rapid cellular uptake in MDA-MB-231 cells. Colocalization experiments confirmed their accumulation in the endoplasmic reticulum (ER) and their ability to induce pyroptosis. Additionally, both complexes triggered ER stress, leading to increased calreticulin exposure on the cell surface, high-mobility group box 1 secretion, and ATP release, which collectively promoted immunogenic cell death. In vivo, a triple-dose Ir4 vaccine regimen significantly suppressed tumor growth compared to other treatment groups. These findings highlight the potential of Ir4-based novel triple-dose vaccination as a promising cancer immunotherapy strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridiumPyroptosisImmunogenic Cell DeathEndoplasmic ReticulumAntineoplastic AgentsCoordination ComplexesHumansCell Line, TumorAnimalsEndoplasmic Reticulum StressFemaleMiceCalreticulinStructure-Activity RelationshipMDA-MB-231 Cells

Substanzen

IridiumAntineoplastic AgentsCoordination ComplexesCalreticulin

Autor:innen und Institutionen

  • The First Dongguan Affiliated Hospital, School of Pharmacy, Guangdong Medical University, Dongguan 523808, P. R. China.
  • Nancheng Hospital of Dongguan City, Dongguan 523800, P. R. China.
  • Key Laboratory of Computer-Aided Drug Design of Dongguan City, Guangdong Medical University, Dongguan 523808, P. R. China.

ORCID-Profile: Zunnan Huang, Jing Sun

Förderung

  • the Medical Industry Innovation Project of Guangdong Medical University
  • the Key Scientific Research Projects of Colleges and Universities in Guangdong Province

Zitieren

APA

Wu, W., Huang, J., Li, Y., Chen, J., Kuang, X., Ye, M., Chen, R., An, J., Huang, Z., & Sun, J. (2025). Endoplasmic Reticulum-Targeting Iridium(III) Complexes Induce Pyroptosis and Enhance Immunogenic Cell Death in MDA-MB-231 Cells. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00883

Vancouver

Wu W, Huang J, Li Y, Chen J, Kuang X, Ye M, et al. Endoplasmic Reticulum-Targeting Iridium(III) Complexes Induce Pyroptosis and Enhance Immunogenic Cell Death in MDA-MB-231 Cells. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00883

BibTeX
@article{Wu2025,
  author = {Wu, Wei and Huang, Jiaen and Li, Yuling and Chen, Jiaxi and Kuang, Xiaowei and Ye, Manzhen and Chen, Rui and An, Junli and Huang, Zunnan and Sun, Jing},
  title = {Endoplasmic Reticulum-Targeting Iridium(III) Complexes Induce Pyroptosis and Enhance Immunogenic Cell Death in MDA-MB-231 Cells},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00883}
}
Kostenlos starten →